Smoking cessation guidelines for health professionals: an update

This paper updates the evidence base and key recommendations of the Health Education Authority (HEA) smoking cessation guidelines for health professionals published in Thorax in 1998. The strategy for updating the evidence base makes use of updated Cochrane reviews supplemented by individual studies where appropriate. This update contains additional detail concerning the effectiveness of interventions as well as comments on issues relating to implementation. The recommendations include clarification of some important issues addressed only in general terms in the original guidelines. The conclusion that smoking cessation interventions delivered through the National Health Service are an extremely cost effective way of preserving life and reducing ill health remains unchanged. The strategy recommended by the guidelines involves: (1) GPs opportunistically advising smokers to stop during routine consultations, giving advice on and/or prescribing effective medications to help them and referring them to specialist cessation services; (2) specialist smokers' services providing behavioural support (in groups or individually) for smokers who want help with stopping and using effective medications wherever possible; (3) specialist cessation counsellors providing behavioural support for hospital patients and pregnant smokers who want help with stopping; (4) all health professionals involved in smoking cessation encouraging and assisting smokers in use of nicotine replacement therapies (NRT) or bupropion where appropriate. The key points of clarification of the previous guidelines include: (1) primary health care teams and hospitals should create and maintain readily accessible records on the current smoking status of patients; (2) GPs should aim to advise smokers to stop, and record having done so, at least once a year; (3) inpatient, outpatient, and pregnant smokers should be advised to stop as early as possible and the advice recorded in the notes in a readily accessible form; (4) there is currently little scientific basis for matching individual smokers to particular forms of NRT; (5) NHS specialist smokers' clinics should be the first point of referral for smokers wanting help beyond what can be provided through brief advice from the GP; (6) help from trained health care professionals specialising in smoking cessation such as practice nurses should be available for smokers who do not have access to specialist clinics; (7) the provision of specialist NHS smokers' clinics should be commensurate with demand; this is currently one or two full time clinics or their equivalent per average sized health authority, but demand may rise as publicity surrounding the services increases.

[1]  M. Fiore,et al.  Treating tobacco use and dependence: an evidence-based clinical practice guideline for tobacco cessation. , 2002, Chest.

[2]  H. McRobbie,et al.  Nicotine replacement therapy in patients with cardiovascular disease: guidelines for health professionals. , 2001, Addiction.

[3]  R. West,et al.  Smoking cessation and smoking patterns in the general population: a 1-year follow-up. , 2001, Addiction.

[4]  R. West,et al.  Randomized controlled trial of a midwife-delivered brief smoking cessation intervention in pregnancy. , 2001, Addiction.

[5]  R. West,et al.  Smoking cessation activities by general practitioners and practice nurses , 2001, Tobacco control.

[6]  M. Goolsby,et al.  Treating Tobacco Use and Dependence , 2008, Pediatrics.

[7]  J. McElnay,et al.  A randomized controlled trial of a smoking cessation intervention based in community pharmacies. , 2001, Addiction.

[8]  R. Perera,et al.  Nicotine replacement therapy for smoking cessation. , 2012, The Cochrane database of systematic reviews.

[9]  S. May,et al.  Do social support interventions (“buddy systems”) aid smoking cessation? A review , 2000, Tobacco control.

[10]  R. Lloyd‐Mostyn National service framework for coronary heart disease , 2000, BMJ : British Medical Journal.

[11]  R. Windsor,et al.  Recommended cessation counselling for pregnant women who smoke: a review of the evidence , 2000, Tobacco control.

[12]  M. Ernst,et al.  A review of tobacco smoking in adolescents: treatment implications. , 2000, Journal of the American Academy of Child and Adolescent Psychiatry.

[13]  L. Owen,et al.  Impact of a telephone helpline for smokers who called during a mass media campaign , 2000, Tobacco control.

[14]  F. Bull,et al.  How does physician advice influence patient behavior? Evidence for a priming effect. , 2000, Archives of family medicine.

[15]  P. Richman,et al.  The emergency department as a potential site for smoking cessation intervention: a randomized, controlled trial. , 2000, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

[16]  E. Murphy,et al.  Factors influencing discussion of smoking between general practitioners and patients who smoke: a qualitative study. , 2000, The British journal of general practice : the journal of the Royal College of General Practitioners.

[17]  R. West,et al.  Does exercise aid smoking cessation? A systematic review. , 2000, Addiction.

[18]  L. Owen,et al.  Smoking cessation services Implementing the NHS National Plan , 2000 .

[19]  L. Stead,et al.  Group behaviour therapy programmes for smoking cessation. , 2000, The Cochrane database of systematic reviews.

[20]  E. Waters,et al.  Interventions for promoting smoking cessation during pregnancy. , 2000, The Cochrane database of systematic reviews.

[21]  R. West,et al.  Individual differences in preferences for and responses to four nicotine replacement products , 2000, Psychopharmacology.

[22]  D. Schroeder,et al.  Over-the-counter nicotine patch therapy for smoking cessation: results from randomized, double-blind, placebo-controlled, and open label trials. , 1999, American journal of public health.

[23]  A. Steptoe,et al.  Behavioural counselling in general practice for the promotion of healthy behaviour among adults at increased risk of coronary heart disease: randomised trial. , 1999, BMJ.

[24]  R. West,et al.  Randomized comparative trial of nicotine polacrilex, a transdermal patch, nasal spray, and an inhaler. , 1999, Archives of internal medicine.

[25]  A. Lowin,et al.  Prescription of transdermal nicotine patches for smoking cessation in general practice: evaluation of cost-effectiveness , 1999, The Lancet.

[26]  T. Coleman,et al.  Factors associated with the provision of anti-smoking advice by general practitioners. , 1999, The British journal of general practice : the journal of the Royal College of General Practitioners.

[27]  Nicotine replacement to aid smoking cessation , 1999, Drug and therapeutics bulletin.

[28]  Aker,et al.  A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. , 1999, The New England journal of medicine.

[29]  D. Hatsukami,et al.  The smoking cessation efficacy of varying doses of nicotine patch delivery systems 4 to 5 years post-quit day. , 1999, Preventive medicine.

[30]  J. Stapleton Commentary: Progress on nicotine replacement therapy for smokers. , 1999, BMJ.

[31]  M. Raw,et al.  Guidance for commissioners on the cost effectiveness of smoking cessation interventions. Health Educational Authority. , 1998, Thorax.

[32]  M. Raw,et al.  Smoking Cessation Guidelines for Health Professionals—A guide to effective smoking cessation interventions for the health care system , 1998, Thorax.

[33]  K. Wisborg,et al.  A prospective intervention study of stopping smoking in pregnancy in a routine antenatal care setting , 1998, British journal of obstetrics and gynaecology.

[34]  A. McDonald,et al.  Efficacy and safety of an over-the-counter transdermal nicotine patch as an aid for smoking cessation. , 1998, Archives of family medicine.

[35]  W. Dement,et al.  Introduction , 1998, Thorax.

[36]  P. Donnan,et al.  Training pharmacists and pharmacy assistants in the stage-of-change model of smoking cessation: a randomised controlled trial in Scotland , 1998, Tobacco control.

[37]  R. Pill,et al.  Qualitative study of patients' perceptions of doctors' advice to quit smoking: implications for opportunistic health promotion , 1998, BMJ.

[38]  D. Ferry,et al.  Usage patterns of transdermal nicotine when purchased as a non-prescription medicine from pharmacies , 1998, Tobacco control.

[39]  R. Battista,et al.  Predictors of smoking cessation following physicians' counseling. , 1998, Preventive medicine.

[40]  J. E. Anderson,et al.  Transdermal nicotine replacement for hospitalized patients: a randomized clinical trial. , 1998, Preventive medicine.

[41]  S. Shiffman,et al.  Public health benefit of over-the-counter nicotine medications. , 1997, Tobacco control.

[42]  Darrell R. Schroeder,et al.  A Comparison of Sustained-Release Bupropion and Placebo for Smoking Cessation , 1997 .

[43]  N. Benowitz,et al.  Cardiovascular toxicity of nicotine: implications for nicotine replacement therapy. , 1997, Journal of the American College of Cardiology.

[44]  D. Schroeder,et al.  A comparison of sustained-release bupropion and placebo for smoking cessation. , 1997, The New England journal of medicine.

[45]  K. Cummings,et al.  Use of the nicotine skin patch by smokers in 20 communities in the United States, 1992-1993. , 1997, Tobacco control.

[46]  R. Glasgow,et al.  Telephone counseling for smoking cessation: rationales and meta-analytic review of evidence. , 1996, Health education research.

[47]  K. Clark,et al.  The maternal and fetal physiologic effects of nicotine. , 1996, Seminars in perinatology.

[48]  M. Balabanis,et al.  Telephone counseling for smoking cessation: effects of single-session and multiple-session interventions. , 1996, Journal of consulting and clinical psychology.

[49]  I. Campbell,et al.  Transdermal nicotine plus support in patients attending hospital with smoking-related diseases: a placebo-controlled study. , 1996, Respiratory medicine.

[50]  G. Gustavsson,et al.  Dose effects and predictors of outcome in a randomized trial of transdermal nicotine patches in general practice. , 1995, Addiction.

[51]  W. Bailey,et al.  Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study. , 1995, JAMA.

[52]  W. Bailey,et al.  Effects of Smoking Intervention and the Use of an Inhaled Anticholinergic Bronchodilator on the Rate of Decline of FEV1 , 1994 .

[53]  R. Turner,et al.  Promoting smoking cessation in general practice. , 1993, BMJ.

[54]  S. Joshi,et al.  Gender differences and low birth weight with maternal smokeless tobacco use in pregnancy. , 1993, Journal of tropical pediatrics.

[55]  A. Buist,et al.  The Lung Health Study. Baseline characteristics of randomized participants. , 1993, Chest.

[56]  P. Hajek Withdrawal-oriented therapy for smokers. , 1989, British journal of addiction.

[57]  K. Maršál,et al.  Effect of Nicotine on Human Fetal Blood Flow , 1988, Obstetrics and gynecology.

[58]  R. Pill,et al.  Health promotion and the human response to loss: clinical implications of a decade of primary health care research. , 1987, Family practice.

[59]  P. Hajek,et al.  Enhancing the impact of groups: an evaluation of two group formats for smokers. , 1985, The British journal of clinical psychology.

[60]  R. Doll The controlled trial. , 1984, Postgraduate medical journal.

[61]  Correction: Comparison of four methods of smoking withdrawal in patients with smoking related diseases , 1983 .

[62]  M. Russell,et al.  Effect of general practitioners' advice against smoking , 1979, British medical journal.

[63]  N. Wenger,et al.  CARDIOVASCULAR TOXICITY * , 1965, Annals of the New York Academy of Sciences.